August 4, 2017

An immune regulator of addiction

Although drug addiction is classically studied in a neuron-centric way, Vanderbilt researchers have discovered that the immune system also plays a critical role.

by Sanjay Mishra

Drug addiction is often thought of as neuron-centric, but in a study published in the Proceedings of the National Academy of Sciences, M.D./Ph.D. student Daniel Kashima and his mentor, Brad Grueter, Ph.D., show that the immune system also plays a critical role.

They studied the consequence of lacking toll-like receptor 4 (TLR4) on drug-associated physiology and behavior. TLR4 is a pattern-recognition molecule of the innate immune system.

They found that TLR4 knockout mice exhibited a difference in the ability to dynamically change the strength of neuronal connections in the nucleus accumbens core (NAc), a key brain area that processes motivation and reward.

This was associated with a deficit in drug-reward learning. They further showed that microglia, one of the brain’s immune cells, are the primary cell type that expressed TLR4.

These results suggest that TLR4 is a novel regulator of NAc neuronal physiology and associated drug-reward learning.

The research was supported in part by National Institutes of Health grants DA040343 and GM007347.

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to